RM-493
RM-493-002
Phase 1 small_molecule completed
Quick answer
RM-493 for Overweight is a Phase 1 program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Overweight
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed